Search

Search Constraints

You searched for: Author/Creator McNamara, John

Search Results

3. 177 Updated safety analysis of ocrelizumab in multiple sclerosis. Issue 12 (14th November 2019)

9. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials. Issue 4 (April 2023)

10. Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study. (6th October 2020)